BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2006
View Archived Issues
Vascular endothelial growth factor antisense active, well tolerated in cancer patients
Read More
Antiinfluenza activity of traditional Korean medicinal herb extracts
Read More
A role for Omi/HtrA2 in skin inflammation following UVB irradiation
Read More
Alnylam licenses RNAi delivery technology from CBR Institute
Read More
DepoMed finalizes phase III protocol for Gabapentin GR study
Read More
M.D. Anderson Cancer Center spearheading new brain tumor treatments
Read More
Animal models reveal anti-infective efficacy of REP-9
Read More
Experiments show potential of ST-246 against orthopoxvirus infection
Read More
PharmaFrontiers presents data on T-cell and stem cell technology
Read More
Effects on biomarkers point to R-115866 activity in acne
Read More
Angiotech and Genzyme collaborate on innovative surgical oncology treatments
Read More
Qnexa produces weight loss in phase II study
Read More
NG2-73 significantly reduces time to onset of persistent sleep
Read More
CCR5 antagonist INCB-9471 begins phase I study
Read More
CTA-002 produces tumor suppression in prostate cancer model
Read More
New phase I/II study evaluating picoplatin for colorectal cancer
Read More
Laureate Pharma and Iconic Therapeutics sign hI-con1 manufacturing agreement
Read More
NephroGenex licenses Pyridorin rights
Read More
Fast track designation for Cell Genesys' GVAX immunotherapy for prostate cancer
Read More
Diatos acquires rights to DaunoXome
Read More
Elocalcitol shows efficacy in overactive bladder phase II study
Read More
Vanadium complex with insulin-mimetic activities
Read More
SurModics grants Bausch & Lomb genistein license in retinal diseases
Read More
Fast track status for BiovaxID
Read More
Recent patents report novel analgesic agents
Read More
Novel agents for treating neurological disorders disclosed in recent patent literature
Read More
Recent patents describe new diabetic treatment options
Read More
Taisho reports preclinical data on prostanoid receptor agonist for atopic dermatitis
Read More
New foscarnet derivative with activity against resistant HIV reported by Chimerix
Read More
Novel HIV-1 protease inhibitor demonstrates efficacy and good cross-resistance profile in vitro
Read More